Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Immunoassay Evaluated for Cardiac Troponin

By LabMedica International staff writers
Posted on 05 Feb 2013
The analytical performance of an immunoenzymometric assay for the cardiac troponin (cTnI) has been appraised and compared with other methods. More...


The test is a two-site immunoenzymometric assay, which uses a combination of two monoclonal antibodies, respectively directed to 41–49 and 87–91 amino acids of the cTnI peptide chain, and the ternary troponin ITC complex as a calibration antigen.

Scientists at the Fondazione Toscana G. Monasterio (Pisa, Italy) evaluated the assay in 452 healthy individuals of which 326 were males and 126 were female. The median age was 45 years with a range between 17 to 76 years. The study participants were recruited from laboratory staff, blood donors, or voluntary subjects, included in screening programs for preventive medicine.

The immunoenzymometric assay for the cTnI evaluated in the study was the Tosoh ST AIA-PACK cTnI 3rd-Generation, and it uses the automated AIA-2000 platform (Tosoh Corporation, Tokyo, Japan). The third-generation AIA-Pack assay for cTnI showed an improved analytical sensitivity and reproducibility, especially at very low cTnI concentrations compared to the previous second-generation AIA-Pack assay. The values of the third-generation assay were a limit of detection (LoD) at 8.7 ng/L and the limit of quantitation (LoQ) at 100 ng/L. The LoD and 10% LoQ values of the second-generation assay reported previously were 38 ng/L and 130 ng/L, respectively.

The third-generation AIA-Pack Tosoh assay for cTnI showed a very close agreement throughout all the working range with the Access AccuTnI Beckman–Coulter method (Beckman Coulter, Inc.; Fullerton, CA, USA). Close concordance was also demonstrated between the cTnI measured by Tosoh methods and those of cTnT measured with ECLIA Roche method (Roche Diagnostics, Mannheim, Germany). The authors concluded that their results imply that the third generation AIA-Pack assay is suitable for the clinical evaluation of patients with cardiac diseases. The study was published in the January 2013 issue of the journal Clinica Chimica Acta.

Related Links:
Fondazione Toscana G. Monasterio
Beckman Coulter Inc.
Roche Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.